Susquehanna International Group, LLP Amneal Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

A detailed history of Susquehanna International Group, LLP transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 666,754 shares of AMRX stock, worth $4.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

666,754

Previous 718,003 7.14%

Holding current value

$4.36 Million

Previous $4.36 Million 7.3%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$5.24 - $6.34 $268,544 - $324,918	-51,249 Reduced 7.14%	666,754 $4.04 Million
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $242,413 - $448,032	72,147 Added 11.17%	718,003 $4.36 Million
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $1.3 Million - $2.15 Million	469,308 Added 265.82%	645,856 $2.73 Million
Q2 2023 Aug 11, 2023	BUY	$1.33 - $3.1 $166,107 - $387,168	124,893 Added 241.78%	176,548 $547,000
Q1 2023 May 16, 2023	BUY	$1.27 - $2.7 $18,119 - $38,520	14,267 Added 38.16%	51,655 $71,000

Q4 2022 Feb 14, 2023	SELL	$1.96 - $2.61 $52,722 - $70,206	-26,899 Reduced 41.84%	37,388 $74,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $1,472 - $2,638	-729 Reduced 1.12%	64,287 $130,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $593,352 - $879,186	-197,127 Reduced 75.2%	65,016 $207,000
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $966,638 - $1.21 Million	247,856 Added 1734.84%	262,143 $1.09 Million
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $2,385 - $3,533	-604 Reduced 4.06%	14,287 $68,000
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $68,766 - $89,986	-15,955 Reduced 51.72%	14,891 $80,000
Q2 2021 Aug 11, 2021	SELL	$5.12 - $6.82 $107,100 - $142,660	-20,918 Reduced 40.41%	30,846 $158,000
Q4 2020 Feb 16, 2021	BUY	$3.95 - $5.42 $157,146 - $215,629	39,784 Added 332.09%	51,764 $237,000
Q3 2020 Nov 16, 2020	SELL	$3.54 - $5.27 $48,405 - $72,061	-13,674 Reduced 53.3%	11,980 $46,000
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.46 $556,992 - $1.06 Million	-194,074 Reduced 88.32%	25,654 $122,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.35 $219,564 - $477,508	-89,254 Reduced 28.89%	219,728 $765,000
Q4 2019 Feb 14, 2020	SELL	$2.65 - $5.56 $123,752 - $259,646	-46,699 Reduced 13.13%	308,982 $1.49 Million
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $634,094 - $1.97 Million	276,897 Added 351.46%	355,681 $1.03 Million
Q2 2019 Aug 16, 2019	BUY	$6.44 - $14.29 $147,740 - $327,826	22,941 Added 41.08%	78,784 $565,000
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $278,349 - $617,642	43,222 Added 342.46%	55,843 $400,000
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $40,644 - $66,726	3,105 Added 32.63%	12,621 $171,000
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $2.55 Million - $3.77 Million	-155,260 Reduced 94.22%	9,516 $211,000
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $2.3 Million - $3.33 Million	164,776 New	164,776 $2.7 Million

Others Institutions Holding AMRX

# of Institutions

178

Shares Held

107M

Call Options Held

330K

Put Options Held

81.9K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $990M
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Amneal Pharmaceuticals, Inc. Transaction History